Abstract
Itraconazole is an oral triazole with increased activity against a number of localized and disseminated mycoses. This position paper reviews the pharmacokinetics, clinical trials, adverse effects and precautions, and costs of itraconazole, and presents recommendations regarding the drug's use.
Original language | English |
---|---|
Pages (from-to) | 366-369 |
Number of pages | 4 |
Journal | Canadian Journal of Infectious Diseases |
Volume | 7 |
Issue number | 6 |
Publication status | Published - 1996 |
ASJC Scopus Subject Areas
- Microbiology (medical)